Clinical Trials Directory

Trials / Completed

CompletedNCT01180517

The Paclitaxel-Eluting Percutaneous Coronary Angioplasty (PTCA)-Balloon Catheter for the Treatment of Coronary Bifurcations

The Paclitaxel-Eluting PTCA-Balloon Catheter for the Treatment of Coronary Bifurcations

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Ralf Degenhardt, PhD · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The intention of this trial is to assess the safety and efficacy of Drug Eluting Balloon (DEB) application (SeQuent Please) to the side branch in percutaneous coronary intervention (PCI) of Medina 0,0,1 coronary bifurcation lesions. Patients will be randomized to treatment with Plain Old Balloon Angioplasty (POBA)or treatment with DEB.

Conditions

Interventions

TypeNameDescription
PROCEDUREPercutaneous coronary intervention (PCI)balloon angioplasty
PROCEDUREPCIballoon angioplasty

Timeline

Start date
2010-11-01
Primary completion
2014-11-01
Completion
2016-02-01
First posted
2010-08-12
Last updated
2016-02-19

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01180517. Inclusion in this directory is not an endorsement.

The Paclitaxel-Eluting Percutaneous Coronary Angioplasty (PTCA)-Balloon Catheter for the Treatment of Coronary Bifurcati (NCT01180517) · Clinical Trials Directory